These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 21256389)

  • 21. Making sense of prostate specific antigen: improving its predictive value in patients undergoing prostate biopsy.
    Nam RK; Toi A; Trachtenberg J; Klotz LH; Jewett MA; Emami M; Sugar L; Sweet J; Pond GR; Narod SA
    J Urol; 2006 Feb; 175(2):489-94. PubMed ID: 16406978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The clinical usefulness of routine biopsy of the transition zone in the diagnosis of prostate cancer].
    Morote Robles J; López Pacios M; Encabo Duró G; de Torres Ramírez I
    Actas Urol Esp; 1999; 23(7):583-6. PubMed ID: 10488612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of digital rectal examination, flexible cystoscopy and prostatic biopsy on free and total prostate specific antigen, and the free-to-total prostate specific antigen ratio in clinical practice.
    Collins GN; Martin PJ; Wynn-Davies A; Brooman PJ; O'Reilly PH
    J Urol; 1997 May; 157(5):1744-7. PubMed ID: 9112518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of free and total prostate specific antigen in identifying patients for prostatic biopsy and its relationship to Gleason score and number of positive cores.
    Bulbul MA; Khauli RB; Nasr R; Hemady K; Wazzan W
    J Med Liban; 2000; 48(2):59-62. PubMed ID: 11028151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsy.
    Issa MM; Zasada W; Ward K; Hall JA; Petros JA; Ritenour CW; Goodman M; Kleinbaum D; Mandel J; Marshall FF
    Cancer Detect Prev; 2006; 30(3):269-75. PubMed ID: 16844319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The detection rate of prostate cancer in different prostate-specific antigen (PSA) levels in Chinese men].
    Li M; Na YQ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):16-8. PubMed ID: 18346372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection rate of prostate cancer according to prostate-specific antigen and digital rectal examination in Korean men: a nationwide multicenter study.
    Seo HK; Chung MK; Ryu SB; Lee KH;
    Urology; 2007 Dec; 70(6):1109-12. PubMed ID: 18158028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP.
    Hara N; Koike H; Nobushita T; Miyajima N; Kawaguchi M; Nishiyama T; Takahashi K; Hohenfellner R
    Urol Oncol; 2010; 28(4):355-9. PubMed ID: 19110451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
    Shao Q; Song J; Zhou ZJ; Du LD
    Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?
    de la Taille A; Rubin MA; Bagiella E; Olsson CA; Buttyan R; Burchardt T; Knight C; O'Toole KM; Katz AE
    J Urol; 1999 Jul; 162(1):103-6. PubMed ID: 10379750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of digital rectal examination and prostate specific antigen in detecting carcinoma prostate.
    Iqbal N; Bhatti AN; Husain S
    J Coll Physicians Surg Pak; 2003 Jun; 13(6):340-2. PubMed ID: 12814533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective, randomized trial comparing the Vienna nomogram to an eight-core prostate biopsy protocol.
    Lecuona A; Heyns CF
    BJU Int; 2011 Jul; 108(2):204-8. PubMed ID: 21087452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions.
    de la Taille A; Irani J; Graefen M; Chun F; de Reijke T; Kil P; Gontero P; Mottaz A; Haese A
    J Urol; 2011 Jun; 185(6):2119-25. PubMed ID: 21496856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can prostate specific antigen derivatives reduce the frequency of unnecessary prostate biopsies?
    Klein EA
    J Urol; 1996 Aug; 156(2 Pt 1):443-4. PubMed ID: 8683698
    [No Abstract]   [Full Text] [Related]  

  • 36. The interplay between obesity and the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer.
    Granieri MA; Freedland SJ
    BJU Int; 2013 Aug; 112(4):E272. PubMed ID: 23879911
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial: Lessons learned from prostate biopsies.
    McCullough DL
    J Urol; 2002 Nov; 168(5):2000. PubMed ID: 12394694
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial comment from Dr Urakami to impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
    Urakami S
    Int J Urol; 2014 Oct; 21(10):990-1. PubMed ID: 24909066
    [No Abstract]   [Full Text] [Related]  

  • 39. Editorial comment from Dr Simonato and Dr Romagnoli to impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
    Simonato A; Romagnoli A
    Int J Urol; 2014 Oct; 21(10):991. PubMed ID: 24931339
    [No Abstract]   [Full Text] [Related]  

  • 40. Suspected clinical T3 prostate cancer is associated with a high rate of negative extended biopsies: clinical implications.
    Capitanio U; Karakiewicz PI; Jeldres C; Briganti A; Salonia A; Cestari A; Guazzoni G; Rigatti P; Montorsi F
    Eur Urol; 2009 Jan; 55(1):253-4. PubMed ID: 18513849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.